研究单位：[1]Capital Medical University[2]Suzhou Municipal Hoapital,Suzhou, An Hui, China[3]Xuanwu Hospital, Capital Medical University,Beijing, Beijing, China, 100053[4]The Central Hospital of Luohe City,Luohe, Henan, China[5]Luzhou People's Hospital,Luzhou, Sichuan, China[6]Xiangtan Central Hospital,Xiangtan, China[7]The Fifth Affiliated Hospital of Zhengzhou University,Zhengzhou, China[8]The First Affiliated Hospital of Zhengzhou University,Zhengzhou, China
研究目的：
After intravenous thrombolysis, the overall recanalization rate is 46%, and recclusion after initial recanalization occurs in 14-34%. In the MR TEA, the investigators compared the effects of administration of tirofiban in acute ischemic stroke patients treated with intravenous alteplase thrombolysis with alteplase alone.
